These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17447002)

  • 1. Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke.
    Krzystanek E; Krzystanek M; Opala G; Trzeciak HI; Siuda J; Małecki A
    J Neural Transm (Vienna); 2007; 114(8):1033-9. PubMed ID: 17447002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment.
    Gattaz WF; Forlenza OV; Talib LL; Barbosa NR; Bottino CM
    J Neural Transm (Vienna); 2004 May; 111(5):591-601. PubMed ID: 15088152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relevance of metabolism of membrane phospholipids for Alzheimer dementia].
    Gattaz WF; Levy R; Cairns NJ; Förstl H; Braus DF; Maras A
    Fortschr Neurol Psychiatr; 1996 Jan; 64(1):8-12. PubMed ID: 8850090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.
    Gattaz WF; Cairns NJ; Levy R; Förstl H; Braus DF; Maras A
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(3):129-31. PubMed ID: 8739397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet beta-secretase activity is increased in Alzheimer's disease.
    Johnston JA; Liu WW; Coulson DT; Todd S; Murphy S; Brennan S; Foy CJ; Craig D; Irvine GB; Passmore AP
    Neurobiol Aging; 2008 May; 29(5):661-8. PubMed ID: 17174011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choline acetyltransferase activity in vascular dementia and stroke.
    Sharp SI; Francis PT; Elliott MS; Kalaria RN; Bajic N; Hortobagyi T; Ballard CG
    Dement Geriatr Cogn Disord; 2009; 28(3):233-8. PubMed ID: 19776575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study.
    McGuinness B; Fuchs M; Barrett SL; Passmore AP; Johnston JA
    J Alzheimers Dis; 2016; 49(4):1095-103. PubMed ID: 26639974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased phospholipase A2 activity in Alzheimer brains.
    Gattaz WF; Maras A; Cairns NJ; Levy R; Förstl H
    Biol Psychiatry; 1995 Jan; 37(1):13-7. PubMed ID: 7893853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease.
    Liang QC; Jin D; Li Y; Wang RT
    Platelets; 2014; 25(6):433-8. PubMed ID: 24175580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet MAO-B activity as a marker of behavioural characteristics in dementia disorders.
    Parnetti L; Reboldi GP; Santucci C; Santucci A; Gaiti A; Brunetti M; Cecchetti R; Senin U
    Aging (Milano); 1994 Jun; 6(3):201-7. PubMed ID: 7993928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of platelet-leukocyte aggregation and platelet activation in stroke.
    Schmalbach B; Stepanow O; Jochens A; Riedel C; Deuschl G; Kuhlenbäumer G
    Cerebrovasc Dis; 2015; 39(3-4):176-80. PubMed ID: 25720421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia.
    Palmer JC; Kehoe PG; Love S
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):487-97. PubMed ID: 20345647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients.
    Talib LL; Hototian SR; Joaquim HP; Forlenza OV; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2015 Dec; 265(8):701-6. PubMed ID: 25920742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease.
    Forlenza OV; Schaeffer EL; Gattaz WF
    J Neural Transm (Vienna); 2007 Feb; 114(2):231-8. PubMed ID: 17131232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
    Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
    Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.
    Yu PH
    Med Hypotheses; 2001 Aug; 57(2):175-9. PubMed ID: 11461168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical diagnosis of vascular dementia.
    Nagata K; Saito H; Ueno T; Sato M; Nakase T; Maeda T; Satoh Y; Komatsu H; Suzuki M; Kondoh Y
    J Neurol Sci; 2007 Jun; 257(1-2):44-8. PubMed ID: 17445833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer and platelets: low-density platelet populations reveal increased serotonin content in Alzheimer type dementia.
    Milovanovic M; Eriksson K; Winblad B; Nilsson S; Lindahl TL; Post C; Järemo P
    Clin Biochem; 2014 Oct; 47(15):51-3. PubMed ID: 25041722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of platelet phospholipase C activity in patients with Alzheimer disease.
    Matsushima H; Shimohama S; Fujimoto S; Takenawa T; Kimura J
    Alzheimer Dis Assoc Disord; 1995; 9(4):213-7. PubMed ID: 8749610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.